Chromatin modifications associated with diabetes and obesity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 7, 2015, Pages 1557-1561

  Schones, Dustin E ^a   Leung, Amy ^a   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

chromatin; diabetes mellitus; epigenomics; gene environment interaction; obesity

Indexed keywords

ARTICLE; CHROMATIN; DIABETES MELLITUS; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; NONHUMAN; OBESITY; PRIORITY JOURNAL; ANIMAL; BLOOD; CARDIOVASCULAR DISEASE; COMPLICATION; DIABETIC ANGIOPATHY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; NUTRITION; PHYSIOLOGY;

CHROMATIN; GLUCOSE BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHROMATIN; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OBESITY;

EID: 84933046840     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305041     Document Type: Article

References (61)

1. Li B, Carey M, Workman JL., The role of chromatin during transcription. Cell 2007 128 707 719. doi: 10.1016/j.cell.2007.01.015
2. Bernstein BE, Meissner A, Lander ES., The mammalian epigenome. Cell 2007 128 669 681. doi: 10.1016/j.cell.2007.01.033
3. Portela A, Esteller M., Epigenetic modifications and human disease. Nat Biotechnol 2010 28 1057 1068. doi: 10.1038/nbt.1685
4. Bird A., Perceptions of epigenetics. Nature 2007 447 396 398. doi: 10.1038/nature05913
5. Jirtle RL, Skinner MK., Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007 8 253 262. doi: 10.1038/nrg2045
6. Lane M, Robker RL, Robertson SA., Parenting from before conception. Science 2014 345 756 760. doi: 10.1126/science.1254400
7. Daxinger L, Whitelaw E., Understanding transgenerational epigenetic inheritance via the gametes in mammals. Nat Rev Genet 2012 13 153 162. doi: 10.1038/nrg3188
8. Friedman JM., Obesity: causes and control of excess body fat. Nature 2009 459 340 342. doi: 10.1038/459340a
9. Loenen WA., S-adenosylmethionine: jack of all trades and master of everything? Biochem Soc Trans 2006 34 Pt 2 330 333. doi: 10.1042/BST20060330
10. Pogribny IP, Tryndyak VP, Bagnyukova TV, Melnyk S, Montgomery B, Ross SA, Latendresse JR, Rusyn I, Beland FA., Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol 2009 51 176 186. doi: 10.1016/j.jhep.2009.03.021
11. Pogribny IP, Karpf AR, James SR, Melnyk S, Han T, Tryndyak VP., Epigenetic alterations in the brains of Fisher 344 rats induced by long-term administration of folate/methyl-deficient diet. Brain Res 2008 1237 25 34. doi: 10.1016/j.brainres.2008.07.077
12. Jiménez-Chillarón JC, Díaz R, Martínez D, Pentinat T, Ramón-Krauel M, Ribó S, Plösch T., The role of nutrition on epigenetic modifications and their implications on health. Biochimie 2012 94 2242 2263. doi: 10.1016/j.biochi.2012.06.012
13. Waterland RA, Jirtle RL., Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003 23 5293 5300
14. Morgan HD, Sutherland HG, Martin DI, Whitelaw E., Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 1999 23 314 318. doi: 10.1038/15490
15. Valette M, Bellisle F, Carette C, Poitou C, Dubern B, Paradis G, Hercberg S, Muzard L, Clément K, Czernichow S., Eating behaviour in obese patients with melanocortin-4 receptor mutations: a literature review. Int J Obes (Lond) 2013 37 1027 1035. doi: 10.1038/ijo.2012.169
16. Duhl DM, Vrieling H, Miller KA, Wolff GL, Barsh GS., Neomorphic agouti mutations in obese yellow mice. Nat Genet 1994 8 59 65. doi: 10.1038/ng0994-59
17. Widiker S, Karst S, Wagener A, Brockmann GA., High-fat diet leads to a decreased methylation of the Mc4r gene in the obese BFMI and the lean B6 mouse lines. J Appl Genet 2010 51 193 197. doi: 10.1007/BF03195727
18. Jun HJ, Kim J, Hoang MH, Lee SJ., Hepatic lipid accumulation alters global histone h3 lysine 9 and 4 trimethylation in the peroxisome proliferator-activated receptor alpha network. PLoS One 2012 7 e44345. doi: 10.1371/journal.pone.0044345
19. Hall E, Volkov P, Dayeh T, Bacos K, Rönn T, Nitert MD, Ling C., Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets. BMC Med 2014 12 103. doi: 10.1186/1741-7015-12-103
20. Zhang X, Zhou D, Strakovsky R, Zhang Y, Pan YX., Hepatic cellular senescence pathway genes are induced through histone modifications in a diet-induced obese rat model. Am J Physiol Gastrointest Liver Physiol 2012 302 G558 G564. doi: 10.1152/ajpgi.00032.2011
21. Leung A, Parks BW, Du J, Trac C, Setten R, Chen Y, Brown K, Lusis AJ, Natarajan R, Schones DE., Open chromatin profiling in mice livers reveals unique chromatin variations induced by high fat diet. J Biol Chem 2014 289 23557 23567. doi: 10.1074/jbc.M114.581439
22. Parks BW, Nam E, Org E, Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab 2013 17 141 152. doi: 10.1016/j.cmet.2012.12.007
23. Parks BW, Sallam T, Mehrabian M, Genetic architecture of insulin resistance in the mouse. Cell Metab 2015 21 334 346. doi: 10.1016/j.cmet.2015.01.002
24. Multhaup ML, Seldin MM, Jaffe AE, Mouse-human experimental epigenetic analysis unmasks dietary targets and genetic liability for diabetic phenotypes. Cell Metab 2015 21 138 149. doi: 10.1016/j.cmet.2014.12.014
25. Yuan W, Xia Y, Bell CG, An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins. Nat Commun 2014 5 5719. doi: 10.1038/ncomms6719
26. Olsson AH, Volkov P, Bacos K, Dayeh T, Hall E, Nilsson EA, Ladenvall C, Rönn T, Ling C., Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets. PLoS Genet 2014 10 e1004735. doi: 10.1371/journal.pgen.1004735
27. Kato M, Natarajan R., Diabetic nephropathy-emerging epigenetic mechanisms. Nat Rev Nephrol 2014 10 517 530. doi: 10.1038/nrneph.2014.116
28. Reddy MA, Natarajan R., Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res 2011 90 421 429. doi: 10.1093/cvr/cvr024
29. Yuan H, Reddy MA, Sun G, Lanting L, Wang M, Kato M, Natarajan R., Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells. Am J Physiol Renal Physiol 2013 304 F601 F613. doi: 10.1152/ajprenal.00523.2012
30. Sun G, Reddy MA, Yuan H, Lanting L, Kato M, Natarajan R., Epigenetic histone methylation modulates fibrotic gene expression. J Am Soc Nephrol 2010 21 2069 2080. doi: 10.1681/ASN.2010060633
31. Reddy MA, Sumanth P, Lanting L, Yuan H, Wang M, Mar D, Alpers CE, Bomsztyk K, Natarajan R., Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice. Kidney Int 2014 85 362 373. doi: 10.1038/ki.2013.387
32. Reddy MA, Zhang E, Natarajan R., Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 2015 58 443 455. doi: 10.1007/s00125-014-3462-y
33. Miao F, Wu X, Zhang L, Yuan YC, Riggs AD, Natarajan R., Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J Biol Chem 2007 282 13854 13863. doi: 10.1074/jbc.M609446200
34. Miao F, Smith DD, Zhang L, Min A, Feng W, Natarajan R., Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 2008 57 3189 3198. doi: 10.2337/db08-0645
35. Leung A, Trac C, Jin W, Lanting L, Akbany A, Sætrom P, Schones DE, Natarajan R., Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res 2013 113 266 278. doi: 10.1161/CIRCRESAHA.112.300849
36. Villeneuve LM, Reddy MA, Lanting LL, Wang M, Meng L, Natarajan R., Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci USA 2008 105 9047 9052. doi: 10.1073/pnas.0803623105
37. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M., Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008 205 2409 2417. doi: 10.1084/jem.20081188
38. Kameswaran V, Kaestner KH., The Missing lnc(RNA) between the pancreatic β-cell and diabetes. Front Genet 2014 5 200. doi: 10.3389/fgene.2014.00200
39. Leung A, Natarajan R., Noncoding RNAs in vascular disease. Curr Opin Cardiol 2014 29 199 206. doi: 10.1097/HCO.0000000000000054
40. Reddy MA, Chen Z, Park JT, Wang M, Lanting L, Zhang Q, Bhatt K, Leung A, Wu X, Putta S, Sætrom P, Devaraj S, Natarajan R., Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA. Diabetes 2014 63 4249 4261. doi: 10.2337/db14-0298
41. Morán I, Akerman I, van de Bunt M, Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab 2012 16 435 448. doi: 10.1016/j.cmet.2012.08.010
42. Wang F, Deeney JT, Denis GV., Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. Vitam Horm 2013 91 49 75. doi: 10.1016/B978-0-12-407766-9.00003-1
43. Brown JD, Lin CY, Duan Q, NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell 2014 56 219 231. doi: 10.1016/j.molcel.2014.08.024
44. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA., 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008 359 1577 1589. doi: 10.1056/NEJMoa0806470
45. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003 290 2159 2167
46. Anderson JW, Konz EC, Frederich RC, Wood CL., Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr 2001 74 579 584
47. Kramer FM, Jeffery RW, Forster JL, Snell MK., Long-term follow-up of behavioral treatment for obesity: patterns of weight regain among men and women. Int J Obes 1989 13 123 136
48. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, Proietto J., Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011 365 1597 1604. doi: 10.1056/NEJMoa1105816
49. Rosenbaum M, Hirsch J, Gallagher DA, Leibel RL., Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr 2008 88 906 912
50. Winzell MS, Ahrén B., The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004 53 suppl 3 S215 S219
51. Collins S, Martin TL, Surwit RS, Robidoux J., Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 2004 81 243 248. doi: 10.1016/j.physbeh.2004.02.006
52. Guo J, Jou W, Gavrilova O, Hall KD., Persistent diet-induced obesity in male C57BL/6 mice resulting from temporary obesigenic diets. PLoS One 2009 4 e5370. doi: 10.1371/journal.pone.0005370
53. Jayaraman S., Epigenetic mechanisms of metabolic memory in diabetes. Circ Res 2012 110 1039 1041. doi: 10.1161/CIRCRESAHA.112.268375
54. Miao F, Chen Z, Genuth S, Paterson A, Zhang L, Wu X, Li SM, Cleary P, Riggs A, Harlan DM, Lorenzi G, Kolterman O, Sun W, Lachin JM, Natarajan R, DCCT/EDIC Research Group Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes 2014 63 1748 1762. doi: 10.2337/db13-1251
55. Eckel RH., Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997 96 3248 3250
56. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L., Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet 2014 384 755 765. doi: 10.1016/S0140-6736(14)60892-8
57. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010 127 2893 2917. doi: 10.1002/ijc.25516
58. Sudarsan SS, Paramasivan VK, Arumugam SV, Murali S, Kameswaran M., Comparison of treatment modalities in syndromic children with obstructive sleep apnea-a randomized cohort study. Int J Pediatr Otorhinolaryngol 2014 78 1526 1533. doi: 10.1016/j.ijporl.2014.06.027
59. Manco M., Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease. J Am Coll Nutr 2011 30 295 303
60. Zentner GE, Henikoff S., High-resolution digital profiling of the epigenome. Nat Rev Genet 2014 15 814 827. doi: 10.1038/nrg3798
61. Sharma S, Kelly TK, Jones PA., Epigenetics in cancer. Carcinogenesis 2010 31 27 36. doi: 10.1093/carcin/bgp220